The successful competitive renewal of our Center for Iron and Heme Disorders (CIHD) grant from the NIDDK contains funds to continue Pilot and Feasibility awards. We welcome P&F grants for this next fiscal year. Proposals are due August 10, 2021 and following competitive evaluations, three awards for $33,000 will be awarded September 1, 2021. The funds must be expended by July 31, 2022. The awards will be for one single year with no second-year extensions. The goals of the CIHD are to support research on molecular/cellular biological pathways involved in normal hematopoietic stem cell biology, erythroid differentiation and disease states in addition to iron and heme biology.
The stipulations for the CIHD P&F awards are as follows:
- CIHD members are entitled to apply with a proposal distinct from any previous CIHD proposals from past funding periods.
- CIHD members from outside Utah are welcome to apply if they have an active collaboration with a Utah member of the CIHD.
- A Principal Investigator (PI) must be a tenure track or research track faculty with an appointment of at least 0.75 FTE. Research faculty must have had a two-year residency at their institution prior to funding applications. Proposals that have previously been submitted to an extramural agency and found to be non-competitive will not be reviewed.
- All successful applicants for funding will be asked to present an update of their research at a spring 2022 CIHD symposium.
Checklist for submission
- Abstract: 1 separate page
- 3 pages of project description: significance, background and proposed studies
- Statement of relevance to our CIHD
- Description of CIHD cores to be utilized
- NIH-style biosketch
- Current and pending support
- Proposed budget and justification ($33,000 maximal budget)
- NIH grant submission plans